Goldman Sachs
TRIL

Goldman Sachs’s Trillium Therapeutics Inc. TRIL Stock Holding History

Goldman Sachs’s Portfolio TRIL Stock Details TRIL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
2021
Q3 		$22.2M Buy
2021
Q2 		$4.86M Buy
2021
Q1 		$1.1M Sell
2020
Q4 		$3.61M Buy
2020
Q3 		$2.52M Sell
2020
Q2 		$1.63M Buy
2020
Q1 		$455K Buy